Metraipolis › archive › dc_2270629492ce
FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development — Europe PMC PMID:32883327
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32883327
- DOI
- 10.1186/s13023-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:22:44.750Z
- SHA-256 of the archived text
0ad8f4e2f9f8abc863fed3a23cd188b4464a789742bb1e3c9722efe72c8124d5- Stable URL of this page
https://metraipolis.com/documento/dc_2270629492ce
How to cite
FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development — Europe PMC PMID:32883327 — Europe PMC (en), https://europepmc.org/article/MED/32883327 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2270629492ce (Metraipolis archive dc_2270629492ce, sha256 0ad8f4e2f9f8abc863fed3a23cd188b4464a789742bb1e3c9722efe72c8124d5)
BibTeX
@misc{dc2270629492ce,
title = {FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development — Europe PMC PMID:32883327},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32883327},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2270629492ce; sha256 0ad8f4e2f9f8abc863fed3a23cd188b4464a789742bb1e3c9722efe72c8124d5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/32883327. Agents can read the archived copy with the MCP tool read_document.